Cargando…
The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
The exosome serves as a trafficking vehicle for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells by exosomal PD-L1. Here, we summerize the biogenesis and transport process of exosomal PD-L1. Then,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158891/ https://www.ncbi.nlm.nih.gov/pubmed/32322256 http://dx.doi.org/10.3389/fimmu.2020.00604 |
_version_ | 1783522572446466048 |
---|---|
author | Tang, Yanyan Zhang, Ping Wang, Yumin Wang, Jinpeng Su, Min Wang, Ying Zhou, Lianqing Zhou, Jumei Xiong, Wei Zeng, Zhaoyang Zhou, Yujuan Nie, Shaolin Liao, Qianjin |
author_facet | Tang, Yanyan Zhang, Ping Wang, Yumin Wang, Jinpeng Su, Min Wang, Ying Zhou, Lianqing Zhou, Jumei Xiong, Wei Zeng, Zhaoyang Zhou, Yujuan Nie, Shaolin Liao, Qianjin |
author_sort | Tang, Yanyan |
collection | PubMed |
description | The exosome serves as a trafficking vehicle for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells by exosomal PD-L1. Here, we summerize the biogenesis and transport process of exosomal PD-L1. Then, we focus on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlight the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we discuss the new challenges faced in researching and utilizing exosomal PD-L1. This review may shed light on the exosomal PD-L1 from the bench to the clinic. Exosomes serve as trafficking vehicles for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells through exosomal PD-L1. Here, we have summarized the biogenesis and transport of exosomal PD-L1. Next, we focused on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlighted the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we have discussed the new challenges faced in studying and utilizing exosomal PD-L1. This review may shed light on the translation of exosomal PD-L1 from bench to clinic. |
format | Online Article Text |
id | pubmed-7158891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71588912020-04-22 The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer Tang, Yanyan Zhang, Ping Wang, Yumin Wang, Jinpeng Su, Min Wang, Ying Zhou, Lianqing Zhou, Jumei Xiong, Wei Zeng, Zhaoyang Zhou, Yujuan Nie, Shaolin Liao, Qianjin Front Immunol Immunology The exosome serves as a trafficking vehicle for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells by exosomal PD-L1. Here, we summerize the biogenesis and transport process of exosomal PD-L1. Then, we focus on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlight the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we discuss the new challenges faced in researching and utilizing exosomal PD-L1. This review may shed light on the exosomal PD-L1 from the bench to the clinic. Exosomes serve as trafficking vehicles for transport of programmed death-ligand 1 (PD-L1) into receptor cells. In tumor microenvironment, distant tumor cells can remotely attack activated T cells through exosomal PD-L1. Here, we have summarized the biogenesis and transport of exosomal PD-L1. Next, we focused on the cancer biology of exosomal PD-L1 in immunosuppression and the mechanism by which it inhibits T cells. Finally, we highlighted the prospects of exosomal PD-L1 as a tumor biomarker and its significance in immunotherapy. In addition, we have discussed the new challenges faced in studying and utilizing exosomal PD-L1. This review may shed light on the translation of exosomal PD-L1 from bench to clinic. Frontiers Media S.A. 2020-04-07 /pmc/articles/PMC7158891/ /pubmed/32322256 http://dx.doi.org/10.3389/fimmu.2020.00604 Text en Copyright © 2020 Tang, Zhang, Wang, Wang, Su, Wang, Zhou, Zhou, Xiong, Zeng, Zhou, Nie and Liao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Tang, Yanyan Zhang, Ping Wang, Yumin Wang, Jinpeng Su, Min Wang, Ying Zhou, Lianqing Zhou, Jumei Xiong, Wei Zeng, Zhaoyang Zhou, Yujuan Nie, Shaolin Liao, Qianjin The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title | The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title_full | The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title_fullStr | The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title_full_unstemmed | The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title_short | The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer |
title_sort | biogenesis, biology, and clinical significance of exosomal pd-l1 in cancer |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158891/ https://www.ncbi.nlm.nih.gov/pubmed/32322256 http://dx.doi.org/10.3389/fimmu.2020.00604 |
work_keys_str_mv | AT tangyanyan thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhangping thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangyumin thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangjinpeng thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT sumin thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangying thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhoulianqing thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhoujumei thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT xiongwei thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zengzhaoyang thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhouyujuan thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT nieshaolin thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT liaoqianjin thebiogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT tangyanyan biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhangping biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangyumin biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangjinpeng biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT sumin biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT wangying biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhoulianqing biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhoujumei biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT xiongwei biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zengzhaoyang biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT zhouyujuan biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT nieshaolin biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer AT liaoqianjin biogenesisbiologyandclinicalsignificanceofexosomalpdl1incancer |